High Capacity Poly(2-Oxazoline) Formulation of TLR 7/8 Agonist Extends Survival in a Chemo-Insensitive, Metastatic Model of Lung Adenocarcinoma
doi 10.1101/2019.12.12.874198
Full Text
Open PDFAbstract
Available in full text
Date
December 12, 2019
Authors
Publisher
Cold Spring Harbor Laboratory